ARCHIVES

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: HHS Won’t Nominate Fischbach for NIH; Kirschstein in Charge

April 28, 2000

FDA Advisors Okay NCI Toxicology Proposals, Write New Clinical Guidelines, Approve AIN DA

October 19, 1979

Two New Communications Contracts Approved

October 18, 1985

As Zeneca Buys Salick, Implications For Oncology Managed Care Uncertain

April 4, 1997

Late Effects In Breast Cancer Treatment Found In Study

January 25, 2002

Cooperative Groups Fight Back: Members Seek Move To Multidisciplinary Approach, More Funds

May 30, 1975